MALAT1 and pancreatic neoplasm: TCDD exposure resulted in a significant increase in MALAT1, EZH2, and H3K27me3 levels but exposure to AhR antagonists exhibited the reversed functions of MALAT1, EZH2, and H3K27me3 in AhR-overexpressing pancreatic cancer cells.